Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma

PURPOSE: Romidepsin is a potent histone deacetylase inhibitor under clinical development. The objective of this study was to evaluate the effect of demographic, clinical and pharmacogenetic covariates on the pharmacokinetics of romidepsin in patients with T-cell lymphoma. EXPERIMENTAL DESIGN: Pharma...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Woo, Sukyung, Gardner, Erin R., Chen, Xiaohong, Ockers, Sandra B., Baum, Caitlin E., Sissung, Tristan M., Price, Douglas K., Frye, Robin, Piekarz, Richard L., Bates, Susan E., Figg, William D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2707030/
https://ncbi.nlm.nih.gov/pubmed/19228751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1215
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak